LabCorp
LH
#1081
Rank
NZ$37.49 B
Marketcap
NZ$457.20
Share price
1.60%
Change (1 day)
7.98%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2026 (TTM): NZ$19.40

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$19.59. In 2025 the company made an earnings per share (EPS) of NZ$18.16 an increase over its 2024 EPS that were of NZ$15.33.

EPS history for LabCorp from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$19.406.87%
2025NZ$18.1618.45%
2024NZ$15.3389.15%
2023NZ$8.10-66.26%
2022NZ$24.02-43.33%
2021NZ$42.3854.11%
2020NZ$27.5089.43%
2019NZ$14.52-3.33%
2018NZ$15.02-29.7%
2017NZ$21.3675.74%
2016NZ$12.1663.19%
2015NZ$7.45-28.4%
2014NZ$10.40-6.13%
2013NZ$11.085.2%
2012NZ$10.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$23.62 20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.81-19.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.07-105.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.55-81.87%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.36-101.85%๐Ÿ‡บ๐Ÿ‡ธ USA